Science, Cancer, and the Geneticization of Drug Testing
Series: Genetics and Society
Controlling Pharmaceutical Risks is a case study of changes in drug testing since the late 1990s, specifically geneticization of carcinogenic risk assessment and regulation of pharmaceuticals. Radically new ways of determining whether medical drugs might cause cancer have been established...
To Be Published April 30th 2016 by Routledge
Although the two major research areas of the "Self" and "Social Relationships" have flourished, they have done so largely independently of each other. More and more research, however, has indicated that relationships shape the nature of the self and identity, and that self-views influence...
To Be Published August 21st 2015 by Psychology Press
The battle over the world's most controversial sleeping pill
How do drugs get to the market? What controls are there and what procedures for monitoring their effects? And how adequate are the regulators in protecting public health when new drugs have serious side effects? The Therapeutic Nightmare tells the story of the sleeping pill Halcion - a story which...
Published October 1st 2009 by Routledge
Competition, Expertise and Public Health
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations,it provides the first major critical examination of the new Europeanised...
Published September 28th 2000 by Routledge
Controversy And Bias In Drug Regulation
Drug disasters from Thalidomide to Opren, and other less dramatic cases of drug injury, raise questions about whether the testing and control of medicines provides satisfactory protection for the public. In this revealing study, John Abrahan develops a theoretically challenging realist approach, in...
Published June 29th 1995 by Routledge